NVIV - InVivo Therapeutics Holdings Corp.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending12/31/201712/31/201612/31/201512/31/2014
Current Assets
Cash And Cash Equivalents12,91021,46414,92013,459
Short Term Investments-11,5775,274-
Net Receivables----
Inventory----
Other Current Assets3613613611,043
Total Current Assets13,80633,85320,73914,953
Long Term Investments----
Property Plant and Equipment1575109381,605
Goodwill----
Intangible Assets617896114
Accumulated Amortization----
Other Assets213431921
Deferred Long Term Asset Charges----
Total Assets14,04534,78421,79216,693
Current Liabilities
Accounts Payable9881,011521569
Short/Current Long Term Debt8521,2751,6701,938
Other Current Liabilities341,4552,0227,338
Total Current Liabilities3,1124,8483,3128,784
Long Term Debt4008521,2751,600
Other Liabilities423135276391
Deferred Long Term Liability Charges----
Minority Interest----
Negative Goodwill----
Total Liabilities3,9355,8354,86310,775
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock1111
Retained Earnings-183,907-157,007-133,569-100,255
Treasury Stock----
Capital Surplus194,016185,955150,497106,172
Other Stockholder Equity----
Total Stockholder Equity10,11028,94916,9295,918
Net Tangible Assets10,04928,87116,8335,804